NYMC Faculty Publications
Iloprost: Old and New Indications
Author Type(s)
Faculty
DOI
10.1097/CRD.0000000000000839
Journal Title
Cardiology in Review
Document Type
Article
Publication Date
1-3-2025
Department
Medicine
Disciplines
Medicine and Health Sciences
Abstract
Iloprost is a synthetic long-acting prostacyclin-analog drug used to treat various vascular diseases. The Federal Drug Administration approved the drug in 2004 for pulmonary arterial hypertension, and it has since been shown to be helpful in other vascular conditions such as scleroderma and Raynaud phenomenon. The Federal Drug Administration has now approved the use of iloprost for severe frostbite. This review summarizes the pharmacologic properties of iloprost, its clinical applications, and potential therapeutic benefits in vascular conditions.
Recommended Citation
Banerji, B., Parikh, M. A., Minkin, R., Frishman, W. H., & Peterson, S. J. (2025). Iloprost: Old and New Indications. Cardiology in Review. https://doi.org/10.1097/CRD.0000000000000839
